Thermo Fisher Scientific Stock News

Shares in GENinCode PLC (AIM:GENI) jumped 34% to 4.02p after the predictive genetics group unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific to manufacture, sell and distribute its CARDIO inCode-Score test. The agreement covers the US and the Europe, Middle East and Africa region.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region's rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess De...

The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.

The Top 15 High-Growth Dividend Stocks for December 2025 offer a 1.58% yield and 20.97% five-year dividend growth, appearing 33% undervalued. The watchlist's goal is a 12% long-term CAGR, with November gains moving closer to this target despite trailing SPY and VIG year-to-date. Quality and Value tilts are tested for superior returns, with the Value portfolio showing higher yields and the Quali...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer....

A common strategy among retail investors is to mirror the investment moves of successful firms and market leaders. Poring over the Form 13-F results of gurus like Warren Buffett can reveal valuable insights, albeit on a delayed schedule.

WALTHAM, Mass.--(BUSINESS WIRE)--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an industry-first all-in-one quantitative Polymerase Chain Reaction (PCR)-based test developed in collaboration with Coca-Cola Europacific Partners. Now part of the Thermo Scientific SureTect PCR System...